BlackRock’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-357,192
| Closed | -$50K | – | 5309 |
|
|
2024
Q1 | $50K | Sell |
357,192
-430
| -0.1% | -$60 | ﹤0.01% | 4808 |
|
|
2023
Q4 | $52K | Sell |
357,622
-13,021
| -4% | -$1.89K | ﹤0.01% | 4886 |
|
|
2023
Q3 | $64.9K | Sell |
370,643
-4,146
| -1% | -$726 | ﹤0.01% | 4886 |
|
|
2023
Q2 | $1.17M | Buy |
374,789
+55,269
| +17% | +$172K | ﹤0.01% | 4165 |
|
|
2023
Q1 | $818K | Buy |
319,520
+22,197
| +7% | +$56.8K | ﹤0.01% | 4306 |
|
|
2022
Q4 | $443K | Sell |
297,323
-14,907
| -5% | -$22.2K | ﹤0.01% | 4561 |
|
|
2022
Q3 | $543K | Sell |
312,230
-2,429
| -0.8% | -$4.22K | ﹤0.01% | 4614 |
|
|
2022
Q2 | $410K | Sell |
314,659
-6,633
| -2% | -$8.64K | ﹤0.01% | 4745 |
|
|
2022
Q1 | $765K | Buy |
321,292
+149,253
| +87% | +$355K | ﹤0.01% | 4669 |
|
|
2021
Q4 | $790K | Sell |
172,039
-13,871
| -7% | -$63.7K | ﹤0.01% | 4666 |
|
|
2021
Q3 | $1.51M | Buy |
185,910
+769
| +0.4% | +$6.23K | ﹤0.01% | 4370 |
|
|
2021
Q2 | $1.82M | Sell |
185,141
-406,586
| -69% | -$4M | ﹤0.01% | 4244 |
|
|
2021
Q1 | $5.22M | Buy |
591,727
+54,762
| +10% | +$483K | ﹤0.01% | 3865 |
|
|
2020
Q4 | $5.49M | Buy |
536,965
+114,325
| +27% | +$1.17M | ﹤0.01% | 3594 |
|
|
2020
Q3 | $3.82M | Buy |
422,640
+25,463
| +6% | +$230K | ﹤0.01% | 3594 |
|
|
2020
Q2 | $2.84M | Buy |
397,177
+325,620
| +455% | +$2.33M | ﹤0.01% | 3644 |
|
|
2020
Q1 | $680K | Buy |
71,557
+3,923
| +6% | +$37.3K | ﹤0.01% | 3911 |
|
|
2019
Q4 | $890K | Buy |
+67,634
| New | +$890K | ﹤0.01% | 3972 |
|